Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GeneNews Ltd Announces Management And Board Changes


Monday, 15 Jul 2013 08:30am EDT 

GeneNews Ltd announced Dr. Heiner Dreismann has stepped down as GeneNews' Interim CEO, but continues as the Company's Lead Director. James Howard-Tripp has been appointed Executive Chair of GeneNews' Board, succeeding Rory Riggs, who has stepped down as Chair, but remains a Director. 

Company Quote

1.25
0.0 +0.00%
3:05pm EDT